Reconsideration of the nomenclature and disease definition of burning mouth syndrome: an international Delphi survey

2021 ◽  
Vol 131 (4) ◽  
pp. e111-e112
Author(s):  
Milda Chmieliauskaite ◽  
Elisabeth Stelson ◽  
Joel Epstein ◽  
Gary Klasser ◽  
Craig Miller
Trials ◽  
2021 ◽  
Vol 22 (1) ◽  
Author(s):  
Barbara Carey ◽  
Arwa M. Farag ◽  
Cibele Nasri-Heir ◽  
Gary D. Klasser ◽  
Anura Ariyawardana ◽  
...  

An amendment to this paper has been published and can be accessed via the original article.


Trials ◽  
2020 ◽  
Vol 21 (1) ◽  
Author(s):  
B. Carey ◽  
A. M. Farag ◽  
C. Nasri-Heir ◽  
G. D. Klasser ◽  
A. Ariyawardana ◽  
...  

2018 ◽  
Vol 14 (3) ◽  
pp. 5-10
Author(s):  
Евгений Васенев ◽  
Evgenij Vasenev ◽  
Ирина Алеханова ◽  
Irina Alekhanova ◽  
Александра Попова ◽  
...  

Background. The article has explored the problem of treatment of patients with burning mouth syndrome. The efficiency of drug therapy was estimated, depending on the duration of the disease. The analysis of the clinical presentation, the duration of the disease, the results of psychometric testing and the terms of remission were carried out. Objectives. To estimate the efficiency of conventional drug therapy in patients with burning mouth syndrome, without any additional methods of treatment, depending on the duration of the disease. Methods. A clinical study of 3 groups: 74 patients, aged 49 to 72 years with the diagnosis of burning mouth syndrome (glossodynia (K 14.1) was conducted. The patients were grouped according to the duration of the disease. The examination included the definition of neurostomatological status, psychometric and general clinical studies. All patients were treated with the same type of medication. The results of the treatment were evaluated according to subjective evidences of patients and the terms of remission. The effectiveness of the therapy was defined as good, satisfactory and unsatisfactory. Results. The research revealed a reducing trend of the clinical response in patients with burning mouth syndrome, who suffered from the disease for about a year or more. So in the 1st group a good long-term result was observed in 63% of patients. Whereas in the third group this measure was only 29%, that was 2.5 times lower. The unsatisfactory effect of treatment in the 1st group was only 14%, and it was 2 times more in the third group of patients. Conclusions. Drug therapy has a satisfactory therapeutic action (reducing the intensity of complaints and improving the general state of the patient). But only such patients who first consulted a doctor about burning mouth syndrome during a few months from the onset of the disease and who have emotional stability of the mentality can expect a good effect from pharmacotherapy.


Author(s):  
Jae Won Chang ◽  
Chul-Ho Kim

BDJ ◽  
2021 ◽  
Vol 230 (2) ◽  
pp. 92-92
Author(s):  
Reena Wadia

2021 ◽  
Author(s):  
Jerome R. Lechien ◽  
Stéphane Hans ◽  
Lisa G. De Marrez ◽  
Didier Dequanter ◽  
Alexandra Rodriguez ◽  
...  

Oral Diseases ◽  
2019 ◽  
Vol 25 (S1) ◽  
pp. 141-156 ◽  
Author(s):  
Anura Ariyawardana ◽  
Milda Chmieliauskaite ◽  
Arwa M. Farag ◽  
Rui Albuquerque ◽  
Heli Forssell ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document